Andres Vargas-Toscano
Overview
Explore the profile of Andres Vargas-Toscano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
47
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Du R, Sanin A, Shi W, Huang B, Nickel A, Vargas-Toscano A, et al.
Front Pharmacol
. 2024 Oct;
15:1468920.
PMID: 39386028
Glioblastoma (GBM) is the most commonly occurring and most aggressive primary brain tumor. Transcriptomics-based tumor subtype classification has established the mesenchymal lineage of GBM (MES-GBM) as cancers with particular aggressive...
2.
Levy T, Voeltzke K, Hruby L, Alasad K, Bas Z, Snaebjornsson M, et al.
Nat Commun
. 2024 May;
15(1):4083.
PMID: 38744825
Energetic stress compels cells to evolve adaptive mechanisms to adjust their metabolism. Inhibition of mTOR kinase complex 1 (mTORC1) is essential for cell survival during glucose starvation. How mTORC1 controls...
3.
Vargas-Toscano A, Janiak C, Sabel M, Kahlert U
J Pers Med
. 2021 Sep;
11(9).
PMID: 34575669
Efficient transdisciplinary cooperation promotes the rapid discovery and clinical application of new technologies, especially in the competitive sector of oncology. In this review, written from a clinical-scientist point of view,...
4.
Vargas-Toscano A, Nickel A, Li G, Kamp M, Muhammad S, Leprivier G, et al.
Cancers (Basel)
. 2020 Dec;
12(12).
PMID: 33371210
Glioblastoma (GBM) is a lethal disease with limited clinical treatment options available. Recently, a new inhibitor targeting the prominent cancer signaling pathway mTOR was discovered (Rapalink-1), but its therapeutic potential...
5.
Vargas-Toscano A, Khan D, Nickel A, Hewera M, Kamp M, Fischer I, et al.
CNS Oncol
. 2020 May;
9(2):CNS58.
PMID: 32462934
Glioblastoma is a heterogeneous lethal disease, regulated by a stem-cell hierarchy and the neurotransmitter microenvironment. The identification of chemotherapies targeting individual cancer stem cells is a clinical need. A robotic...
6.
Benedetti-Isaac J, Torres-Zambrano M, Vargas-Toscano A, Perea-Castro E, Alcala-Cerra G, Furlanetti L, et al.
Epilepsia
. 2015 Jul;
56(7):1152-61.
PMID: 26146753
Objectives: The aim of this study was to analyze the impact of deep brain stimulation (DBS) of the posteromedial hypothalamus (pHyp) on seizure frequency in patients with drug-resistant epilepsy (DRE)...